[IMPORTANCE OF A NEW STEROID DERIVATIVE WITH DYNAMOGENIC AND DELAYED ACTION (19-NOR-ANDROSTENOLONE UNDECYLATE) (DYNABOLON OR TH 25 D) IN CHRONIC EMACIATED AND ASTHENIC PULMONARY PATIENTS].
D045930:Anabolic Agents; D003687:Dehydroepiandrosterone; D003692:Delayed-Action Preparations; D004358:Drug Therapy; D004614:Emaciation; D006801:Humans; D008171:Lung Diseases; D009277:Nandrolone / Q000031:analogs & derivatives; D013256:Steroids
D045930:Anabolic Agents; D003692:Delayed-Action Preparations; D013256:Steroids; D003687:Dehydroepiandrosterone; D009277:Nandrolone; C037984:nandrolone undecanoate
ANABOLIC STEROIDS; DRUG THERAPY; EMACIATION; LUNG DISEASES
INTER ET D'UN NOUVEAU D'ERIV'E STEROIDE 'A ACTION DYNAMOG'ENE ET RETARD (UNDECYLATE DE 19 NOR-ANDROSTENOLONE) (DYNABOLON OU TH 25 D) CHEZ LES PULMONAIRES CHRONIQUES AMAIGRIS ET ASTHENIQUES.